Molecular Therapy
Lipid nanoparticles (LNPs) have emerged as promising vehicles for delivering therapeutic payloads for cell and gene therapy. They offer several advantages, such as biocompatibility, low immunogenicity, and the ability to encapsulate a wide range of cargoes, including small molecules, nucleic acids, and proteins. From the development of mRNA vaccines to the targeted delivery of gene editing tools and RNA interference therapeutics, LNPs are driving transformative breakthroughs in treating a myriad of
